We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$711M
AUM Growth
-$230M
Cap. Flow
-$231M
Cap. Flow %
-32.53%
Top 10 Hldgs %
46.66%
Holding
104
New
20
Increased
21
Reduced
18
Closed
42

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$28.9M
2
VRT icon
Vertiv
VRT
+$14.3M
3
SPOT icon
Spotify
SPOT
+$11.3M
4
NFLX icon
Netflix
NFLX
+$8.89M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.8M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$10.9M
2
GLNG icon
Golar LNG
GLNG
+$8.4M
3
REAL icon
The RealReal
REAL
+$8.15M
4
TSM icon
TSMC
TSM
+$7.66M
5
BSX icon
Boston Scientific
BSX
+$7.61M

Sector Composition

Rank Sector Weight
1 Healthcare 27.28%
2 Technology 16.26%
3 Consumer Discretionary 13.3%
4 Industrials 11.04%
5 Communication Services 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GAP
51
The Gap Inc
GAP
$7.37B
$4.4M 0.62%
213,700
-269,500
-56% -$6.06M
LNTH icon
52
Lantheus
LNTH
$6.59B
$4.4M 0.62%
45,100
-12,000
-21% -$1.12M
NET icon
53
Cloudflare
NET
$107B
$4.06M 0.57%
36,000
-35,800
-50% -$4.75M
GH icon
54
Guardant Health
GH
$22.6B
$3.64M 0.51%
+85,500
New +$3.69M
MU icon
55
CALL
Micron Technology
MU
$991B
$3.48M 0.49%
+400
New +$38.4K
DOCS icon
56
CALL
Doximity
DOCS
$4.88B
$2.9M 0.41%
+500
New +$31.6K
WBA
57
PUT
DELISTED
Walgreens Boots Alliance
WBA
$1.68M 0.24%
+1,500
New +$16.3K
RXST icon
58
CALL
RxSight
RXST
$260M
$1.26M 0.18%
+500
New +$14.9K
VMC icon
59
Vulcan Materials
VMC
$36.9B
$1.12M 0.16%
+4,800
New +$1.22M
XENE icon
60
Xenon Pharmaceuticals
XENE
$6.12B
$805K 0.11%
24,000
-48,600
-67% -$1.85M
CLS icon
61
CALL
Celestica
CLS
$36.5B
$788K 0.11%
+100
New +$10.6K
SFM icon
62
Sprouts Farmers Market
SFM
$8.01B
$714K 0.1%
+4,675
New +$697K
AAPL icon
63
PUT
Apple
AAPL
$4.57T
– –
-1,500
Closed -$37.6M
ABVX
64
Abivax
ABVX
$11.4B
– –
-103,929
Closed -$761K
AFRM icon
65
Affirm
AFRM
$25.2B
– –
-81,300
Closed -$4.95M
ARM icon
66
Arm
ARM
$302B
– –
-28,100
Closed -$3.47M
BSX icon
67
Boston Scientific
BSX
$71.5B
– –
-85,200
Closed -$7.61M
CAVA icon
68
CAVA Group
CAVA
$7.27B
– –
-42,100
Closed -$4.75M
CRM icon
69
Salesforce
CRM
$158B
– –
-19,400
Closed -$6.49M
DRUG
70
Bright Minds Biosciences
DRUG
$778M
– –
-15,000
Closed -$540K
EW icon
71
CALL
Edwards Lifesciences
EW
$51.7B
– –
-1,200
Closed -$8.88M
FIVE icon
72
CALL
Five Below
FIVE
$13.5B
– –
-1,000
Closed -$10.5M
FRPT icon
73
Freshpet
FRPT
$3.22B
– –
-49,400
Closed -$7.32M
FSLR icon
74
First Solar
FSLR
$26.9B
– –
-25,100
Closed -$4.42M
GLNG icon
75
Golar LNG
GLNG
$5.13B
– –
-198,500
Closed -$8.4M
1 2
3
4 5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
VCM
Vision Capital Management Portland, Oregon $792M AUM 18.17% 1-Year Est. Return

Atika Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Atika Capital Management held 104 positions worth $711M, down 24% from $941M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Atika Capital Management withdrew a net $231M in Q1 2025, closing 42 positions and reducing 18 holdings. Its most notable exit was United Therapeutics, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Atika Capital Management opened a new position in Teva Pharmaceuticals worth $6.72M.

  • Atika Capital Management's largest Q1 2025 buy was Teva Pharmaceuticals: 436,900 shares worth $6.72M.
  • Atika Capital Management added most to Amazon in Q1 2025, an estimated $28.9M increase.
  • Atika Capital Management's biggest Q1 2025 reduction was The Gap Inc, cutting an estimated $6.06M.
  • Atika Capital Management fully exited United Therapeutics in Q1 2025, selling an estimated $10.9M.
  • Atika Capital Management's ten largest holdings make up 47% of its $711M portfolio in Q1 2025.
  • Atika Capital Management opened 20 new positions and closed 42 in Q1 2025.
  • Atika Capital Management's portfolio value fell 24% quarter-over-quarter to $711M.

Based on Atika Capital Management's 13F filing for Q1 2025, filed 14 May 2025.